Keywords: bentley, revenues, rise, 1st-qtr, usa, pharmaceuticals, posted
Bentley's revenues rise 15.4% for 1st-qtr 2004
Article | 10 May 2004
The USA's Bentley Pharmaceuticals has posted first-quarter 2004 sales of $17.3 million, up 15.4% on the $15.0 million achieved for the comparable quarter last ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
